Terms: = Testicular cancer AND ER, estrogen receptor AND Diagnosis
14 results:
1. Male breast cancer: an update.
Fox S; Speirs V; Shaaban AM
Virchows Arch; 2022 Jan; 480(1):85-93. PubMed ID: 34458944
[TBL] [Abstract] [Full Text] [Related]
2. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
3. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in cancer.
Onyeisi JOS; Lopes CC; Götte M
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810567
[TBL] [Abstract] [Full Text] [Related]
4. Interstitial Leydig Cell Tumorigenesis-Leptin and Adiponectin Signaling in Relation to Aromatase Expression in the Human Testis.
Duliban M; Gorowska-Wojtowicz E; Tworzydlo W; Rak A; Brzoskwinia M; Krakowska I; Wolski JK; Kotula-Balak M; Płachno BJ; Bilinska B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455738
[TBL] [Abstract] [Full Text] [Related]
5. Epidemiology and biological characteristics of male breast cancer in Italy.
Mangone L; Ferrari F; Mancuso P; Carrozzi G; Michiara M; Falcini F; Piffer S; Filiberti RA; Caldarella A; Vitale F; Tumino R; Brustolin A; Tagliabue G; Giorgi Rossi P; Ottini L
Breast Cancer; 2020 Jul; 27(4):724-731. PubMed ID: 32114665
[TBL] [Abstract] [Full Text] [Related]
6. EAA clinical practice guidelines-gynecomastia evaluation and management.
Kanakis GA; Nordkap L; Bang AK; Calogero AE; Bártfai G; Corona G; Forti G; Toppari J; Goulis DG; Jørgensen N
Andrology; 2019 Nov; 7(6):778-793. PubMed ID: 31099174
[TBL] [Abstract] [Full Text] [Related]
7. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance.
Ondrusova M; Suchansky M; Psota M; Zeleny T; Ondrus D
Bratisl Lek Listy; 2018; 119(1):3-5. PubMed ID: 29405722
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Immunophenotypic Characterization of Adult and Fetal Testes, the Excretory Duct System, and testicular and Epididymal Appendages.
Magers MJ; Udager AM; Chinnaiyan AM; French D; Myers JL; Jentzen JM; McHugh JB; Heider A; Mehra R
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):e50-68. PubMed ID: 26867215
[TBL] [Abstract] [Full Text] [Related]
9. Adenocarcinoma of the rete testis with prominent papillary structure and clear neoplastic cells: morphologic and immunohistochemical findings and differential diagnosis.
Huang PW; Chang KM
Indian J Pathol Microbiol; 2015; 58(2):232-4. PubMed ID: 25885143
[TBL] [Abstract] [Full Text] [Related]
10. estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R
Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486
[TBL] [Abstract] [Full Text] [Related]
11. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract] [Full Text] [Related]
12. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
[TBL] [Abstract] [Full Text] [Related]
13. estrogen receptor content in malignant breast tumors in men--a review.
Olsson H
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):283-7. PubMed ID: 14973390
[TBL] [Abstract] [Full Text] [Related]
14. Clinical uses of tumor markers: a critical review.
Duffy MJ
Crit Rev Clin Lab Sci; 2001 Jun; 38(3):225-62. PubMed ID: 11451209
[TBL] [Abstract] [Full Text] [Related]
